RT Journal Article
SR Electronic
T1 THE SEARCH FOR AN ASSOCIATION OF HLA ALLELES AND COVID-19 RELATED MORTALITY IN THE RUSSIAN POPULATION
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.22.20248695
DO 10.1101/2020.12.22.20248695
A1 Valery Cheranev
A1 Irina Bulusheva
A1 Valery Vechorko
A1 Dmitriy Korostin
A1 Denis Rebrikov
YR 2020
UL http://medrxiv.org/content/early/2020/12/24/2020.12.22.20248695.abstract
AB HLA genes play a pivotal role in an immune response via the presentation of pathogen peptides in a complex on the surface of cells of a host organism. Here, we studied the association of class I and class II genes with the severity of COVID-19 infection and HLA allele variants.We performed high-resolution sequencing of class I and class II HLA genes using the sample population of 147 patients who died of COVID-19 and statistically compared our results with the frequencies of the HLA genotypes in a control population of 270 samples.The obtained data demonstrated that 51:05 and 15:18 alleles from locus B* are statistically significantly associated with COVID-19 severity, while C*14:02 allele correlates with the probability of death from COVID-19 for patients without comorbidities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by grant №075-15-2019-1789 from the Ministry of Science and Higher Education of the Russian Federation allocated to the Center for Precision Genome Editing and Genetic Technologies for Biomedicine.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study conformed to the principles of the Declaration of Helsinki. The appropriate institutional review board approval for this study was obtained from the Ethics Committee at Pirogov Medical University. All patients provided written informed consent for the collection of samples, subsequent analysis, and publication thereof.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll received data are available upon request